48,466
edits
(3 intermediate revisions by the same user not shown) | |||
Line 54: | Line 54: | ||
**Gastric antral-type epithelium - may form glands. | **Gastric antral-type epithelium - may form glands. | ||
*Gallbladders with intestinal metaplasia do ''not'' have to be [[submitted in total]].<ref name=uscap2017_akki>Akki ''et al.'' (2017) "Detecting Incidental Gallbladder Adenocarcinoma: When to Submit the Entire Gallbladder". Available at: [http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016 http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016]. United States and Canadian Academy of Pathology Annual Meeting. Accessed on: April 9, 2017.</ref> | *Gallbladders with intestinal metaplasia do ''not'' have to be [[submitted in total]].<ref name=uscap2017_akki>Akki ''et al.'' (2017) "Detecting Incidental Gallbladder Adenocarcinoma: When to Submit the Entire Gallbladder". Available at: [http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016 http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016]. United States and Canadian Academy of Pathology Annual Meeting. Accessed on: April 9, 2017.</ref> | ||
**Adsay ''et al.'' suggests submitting two additional cassettes of tissue.<ref name=pmid23897266>{{cite journal |authors=Adsay V, Saka B, Basturk O, Roa JC |title=Criteria for pathologic sampling of gallbladder specimens |journal=Am J Clin Pathol |volume=140 |issue=2 |pages=278–80 |date=August 2013 |pmid=23897266 |doi=10.1309/AJCPUJPGQIZ6DC6A |url=}}</ref> | |||
DDx: | DDx: | ||
Line 72: | Line 73: | ||
==Sign out== | ==Sign out== | ||
<pre> | |||
Gallbladder, Cholecystectomy: | |||
- Gallbladder wall with focal intestinal metaplasia and mild chronic inflammation. | |||
- Cholelithiasis. | |||
- NEGATIVE for dysplasia. | |||
</pre> | |||
===Block letters=== | |||
<pre> | <pre> | ||
GALLBLADDER, CHOLECYSTECTOMY: | GALLBLADDER, CHOLECYSTECTOMY: |
edits